Scientists found that the therapy restored functional vision to most patients with the rare, inherited blindness called LCA1. LCA1 is caused by having two defective copies of the gene GUCY2D, which is required for the light-sensitive cells in the eyes to function properly.
Scientists at the University of Florida have developed a new gene therapy, which restored helpful vision to patients with rare, inherited blindness.
